Results 181 to 190 of about 18,542 (210)

Galantamin

2023
Helga Peter, Thomas Penzel
openaire   +1 more source

Galantamin

2010
Otto Benkert, Ion Anghelescu, Christoph Fehr, Gerhard Gründer, Philip Heiser, Christoph Hiemke, Christian Lange-Asschenfeldt, M. J. Müller, M. Paulzen, Francesca Regen, Axel Steiger   +10 more
openaire   +1 more source

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

Lancet, The, 2002
Alexander Kurz, Serge Gauthier
exaly  

Synthesis and Pharmacology of Galantamine

Chemical Reviews, 2006
José Marco-Contelles
exaly  

Galantamine

Reactions Weekly, 2018
Tian-Tian Lei, Jin-Hua Wang, Guan-Hua Du
openaire   +2 more sources

Galantamine

Reactions Weekly, 2005
openaire   +1 more source

Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors

Neuropharmacology, 2004
Esperanza Arias, Eva Ales, Maria F Cano-Abad   +2 more
exaly  

Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management

Drug Delivery, 2016
Amira S Hanafy, Ragwa M Farid, Maged W Helmy   +2 more
exaly  

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer’s disease

Biological Psychiatry, 2001
Joseph Coyle
exaly  

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

Lancet Neurology, The, 2009
Alistair Burns, Roberto Bernabei, Lutz Froelich   +2 more
exaly